Q2 2021 Results - Reimagining Medicine slide image

Q2 2021 Results - Reimagining Medicine

Participants Company overview Pharmaceuticals Oncology Financial review Conclusion Appendix References Harry Kirsch Chief Financial Officer Financial review and 2021 guidance 32 Investor Relations | Q2 2021 Results 1 NOVARTIS | Reimagining Medicine
View entire presentation